Vitamin D Improves Clinical Manifestations in Asthmatic Children
Status:
Completed
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
Objectives: Evaluation of the effect of vitamin D supplemental therapy (VDST) on clinical
manifestation of bronchial asthma (BA) as judged by The International Study of Asthma and
Allergies in Childhood (ISAAC) questionnaire and estimated serum levels of immunoglobulin E
(IgE).
Patients & Methods: scores of ISAAC questionnaire and blood samples were obtained for
estimation of serum IgE and 25-hydroxy VD (25-HVD) at booking time (T1) of 102 BA patients.
VDST was provided as 2000 IU daily for 3 and 6 months for patients had moderate and mild HVD,
respectively. At the end of 12-m after start of VDST (T2), ISAAC questionnaire and serum
levels of 25-HVD and IgE were re-evaluated and the percentage of change was calculated.